Overview

Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Status:
Completed
Trial end date:
2020-10-26
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety and efficacy of multiple doses of etokimab in adults with chronic rhinosinusitis with nasal polyps.
Phase:
Phase 2
Details
Lead Sponsor:
AnaptysBio, Inc.
Treatments:
Mometasone Furoate